Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
- 3 November 1994
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (18), 1188-1193
- https://doi.org/10.1056/nejm199411033311803
Abstract
Troglitazone decreases insulin resistance and hyperglycemia in patients with non-insulin-dependent diabetes mellitus (NIDDM), but its effects on subjects without diabetes are not known.This publication has 19 references indexed in Scilit:
- Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima IndiansNew England Journal of Medicine, 1993
- Slow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic ParentsAnnals of Internal Medicine, 1990
- Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distributionDiabetes, 1990
- Diabetes mellitus in the pima indians: Incidence, risk factors and pathogenesisDiabetes/Metabolism Research and Reviews, 1990
- Insulin Insensitivity in Offspring of Parents with Type 2 Diabetes MellitusDiabetic Medicine, 1990
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Risk factors for worsening to diabetes in subjects with impaired glucose toleranceDiabetologia, 1984
- The ten-year follow-up of the Bedford Survey (1962?1972): Glucose tolerance and diabetesDiabetologia, 1982
- Insulin Responses in Equivocal and Definite Diabetes, with Special Reference to Subjects Who Had Mild Glucose Intolerance but Later Developed Definite DiabetesDiabetes, 1977